Related Experiment Video
Updated: Dec 2, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Emerging Issues in Antifungal Resistance
John R Perfect1, Mahmoud Ghannoum2
1Trent Drive, Hanes House, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
Invasive fungal diseases continue to cause substantial mortality in the enlarging immunocompromised population. It is fortunate that the field has moved past amphotericin B deoxycholate as the only available antifungal drug but despite new classes of antifungal agents both primary and secondary drug resistance in molds and yeasts abound. From the rise of multiple-drug-resistant Candida auris to the agrochemical selection of environmental azole-resistant Aspergillus fumigatus, it is and will be critical to understand antifungal drug resistance and both prevent and treat it with new strategies and agents.
Insights
Antifungal drug resistance is a growing threat in invasive fungal diseases, particularly in immunocompromised patients. New strategies are crucial to combat resistant molds and yeasts like Candida auris and Aspergillus fumigatus.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pharmacology
Background:
- Invasive fungal diseases (IFDs) cause significant mortality, especially in immunocompromised individuals.
- While newer antifungal drugs exist, primary and secondary drug resistance in yeasts and molds is increasingly prevalent.
- Emerging resistant strains, such as multidrug-resistant Candida auris and azole-resistant Aspergillus fumigatus, pose serious clinical challenges.
Purpose of the Study:
- To highlight the critical issue of antifungal drug resistance in IFDs.
- To emphasize the need for understanding and addressing resistance mechanisms.
- To underscore the importance of developing novel strategies and agents for prevention and treatment.
Main Methods:
- Literature review of current antifungal drug resistance trends.
- Analysis of emerging resistant fungal pathogens.
- Discussion of clinical implications and future research directions.
Main Results:
- Antifungal drug resistance is a widespread and escalating problem in clinical mycology.
- Specific examples like Candida auris and Aspergillus fumigatus demonstrate the threat of multidrug resistance.
- The efficacy of existing antifungal therapies is compromised by evolving resistance patterns.
Conclusions:
- Understanding antifungal drug resistance is paramount for effective IFD management.
- New therapeutic strategies and antifungal agents are urgently required.
- Combating drug resistance is essential to reduce mortality in immunocompromised populations.
Related Concept Videos
Development of Antibiotic Resistance
Fungal Phylum Microsporidia
Antimicrobial Effectiveness
Fungal Group Zygomycota
Fungal Phylum Ascomycota
Treatment Resistant Cancers

